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This study developed novel triblock pH-responsive polymeric micelles (PMs) using cholic acid-polyethyleneimine-
poly-L-arginine (CA-PEI-pArg) copolymers. PEI provided pH sensitivity, while the hydrophilic cell-penetrating pArg
peptide promoted cellular PM internalization. The copolymers self-assembled into PMs in aqueous solution at
above the critical micelle concentration (2.98 × 10−7 M) and encapsulated doxorubicin in the core region, with a 34.
2% (w/w) entrapment efficiency. PMs showed pH-dependent swelling, increasing in size by almost sevenfold from
pH 7.4 to 5.0. Doxorubicin release was pH-dependent, with about 65% released at pH 5.0, and 32% at pH 7.4.
Cellular uptake, assessed by confocal microscopy and flow cytometry, was enhanced by using doxorubicin-loaded
CA-PEI-pArg PMs, as compared to free doxorubicin and DOX-loaded CA-PEI PMs. Moreover,
24-h incubation of these PMs with a human breast cancer cell line produced greater cytotoxicity than free
doxorubicin. These results indicate that pH-responsive CA-PEI-pArg micelles could provide a versatile delivery
system for targeted cancer therapy using hydrophobic drugs.
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Chemotherapy is one of the most commonly used
approaches to cancer treatment. However, conventional
chemotherapeutics cause numerous unfavorable side
effects owing to poor water solubility, a lack of selectiv-
ity towards cancer cells, and multi-drug resistance [1].
Doxorubicin (DOX) is used to treat breast cancer, ovar-
ian cancer, lymphoma, multiple myeloma, and sarcoma
[2]. However, clinical use of DOX is limited by its side
effects, which include drug resistance and cardiotoxicity.
The P-glycoprotein efflux pump contributes to multi-
drug resistance in cancer cells, reducing the efficacy of
chemotherapeutic agents [3]. Therefore, higher dose of
DOX is needed to achieve the similar chemotherapeutic* Correspondence: mciamin@ukm.edu.my
1Centre for Drug Delivery Research, Faculty of Pharmacy, Universiti
Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300,
Malaysia
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article
International License (http://creativecommons.o
reproduction in any medium, provided you giv
the Creative Commons license, and indicate ifeffect. As a consequence, the high dose of DOX will
eventually causes toxicity effects, which is due to non-
specific targeting of the drug, such as cardiotoxicity and
hematological toxicity. Commercially available formula-
tions of hydrophobic drugs usually contain synthetic
solvents to facilitate parenteral administration. However,
such solvents can cause certain adverse effects during
chemotherapy. For instance, cremophor EL is a vehicle
that is used in such formulations and it has been associ-
ated with severe hypersensitivity reactions, hyperlipid-
emia, and erythrocyte aggregation [4, 5].
To reduce the limitations of chemotherapeutics, a
versatile drug delivery system is needed to deliver drugs
to targeted tumors. In recent years, there have been
many advances in drug delivery involving nano-delivery
systems. Block copolymer micelles (PMs) have advan-
tages over other types of nanoparticles used in drug
delivery, because polymers with unique benefits can beis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
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Characteristics important for drug delivery, including the
size and stability of PMs, loading capacity, and release kin-
etics of the loaded drugs, can be modulated by utilizing a
range of block copolymers [6]. Therefore, self-assembled
PMs can be tailored to optimize their biocompatibility, bio-
degradability, and blood circulation time. In addition, PMs
can be utilized to overcome multi-drug resistance through
passive, folate-mediated, pH-sensitive, and thermo-sensitive
targeting [1]. pH responsiveness is a particularly appealing
targeted drug release strategy, owing to their preferential
drug release at slightly acidic pH in the tumor interstitium
(6.5–7.0) and lysosomal compartment (around 5.0), in com-
parison with that of the normal physiological environment
(pH 7.4) [7]. Therefore, the mildly acidic pH of the tumor
interstitium is considered to be an ideal trigger for drug
delivery systems, because it facilitates programmable release
of anticancer drugs at tumor sites [8]. Recently, the
pH-responsive delivery systems have attracted much atten-
tion in the research of controlled drug delivery [9–12].
Polyethyleneimine (PEI) is a synthetic cationic polymer
with a high amine density that is employed in gene
delivery because it promotes transfection [13]. PEI facili-
tates drug release from the endosomal compartment and
protects it from enzymatic degradation. The cytotoxic
effect of low molecular-weight PEI can be reduced by
conjugating it with biocompatible polymers or hydro-
phobic moieties [13, 14]. Despite its common use in
gene transfection, PEI can also be used in pH-responsive
drug delivery systems. The amine groups in PEI will
undergo protonation in acidic environments and the
repulsive force between protonated amine groups will
then result in a swollen micellar structure. This
phenomenon will destabilize the micellar structure and
eventually increase the release rates of loaded drugs [15].
The cationic peptide, poly-L-arginine (pArg), is a cell-
penetrating peptide that translocates through cell mem-
branes and facilitates cellular uptake. pArg has therefore
been utilized in gene therapy [16], protein/vaccine delivery
[17], and cancer treatment [18]. Recent studies reported
that poly(amino acid)-based nanoparticles could also
effectively translocate through cell membranes [19–22].
Cholic acid (CA) is one of the major bile acids in
the human body, and it is composed of a steroid unit
with three hydroxyl groups and one carboxyl group
[23]. Incorporation of a CA moiety into polymers
improves their biocompatibility [24]. CA is amphi-
philic and organizes into micelles at its critical mi-
celle concentration (CMC). The hydrophobic domains
of CA form the inner core segment and act as a
potential drug-incorporation site in the PM, which
facilitates transportation of the drug cargo across
the cell membrane. In addition, the hydrophilic shell
of CA enhances PM biocompatibility, preventingopsonization by the mononuclear phagocytic system
and prolonging PM circulation in the blood [25].
Herein we introduce a pH-responsive drug delivery sys-
tem conjugated with cell-penetrating peptide to achieve a
stimuli-triggered drug release system, improve the cellular
uptake of drugs, and increase the efficacy of anticancer
drugs towards cancer cell line. The originality of this work
lies on the use of PEI as pH-sensitive moiety and functio-
nalization of micellar surface with cell-penetrating pArg
peptide. The integration of pH-responsive strategy with
cell-penetrating peptide has been relatively less explored.
The combination of pH-sensitive PEI together with cell-
penetrating pArg peptide in a drug delivery system is
expected to provide greater stability and improve drug
efficacy. In addition, the amphiphilic properties of CA
formed the hydrophobic core that was used as a site of en-
trapment for doxorubicin (DOX). The conjugation of CA
to PEI was expected to minimize the cytotoxicity effect
from PEI and improve the biocompatibility of the drug de-
livery system. Hydrophilic pArg and amphiphilic CA were
conjugated to the PEI main chain through carbodiimide-
mediated amide linkage. PEI was used as the backbone of
the triblock copolymer and provided pH sensitivity; while
the hydrophilic cell-penetrating pArg peptide was used to
facilitate the cellular internalization of the PMs.
The aim of this study was to synthesize DOX-loaded
pH-responsive CA-PEI-pArg PMs and investigate the
physicochemical properties and biological responses of
the PMs towards MCF-7 cancer cell line. The in vitro
drug release profile and the cellular targeting of
DOX-loaded PMs towards MCF-7 cells were determined
and evaluated. Later, the in vitro cytotoxicity of the
DOX-loaded PMs against MCF-7 cells was also assessed.
The CA-PEI-pArg PMs were designed to act as a versa-
tile drug delivery system in order to overcome the
limitation of conventional chemotherapeutics.
Methods
Materials
CA, PEI (average molecular weight (MW) approximately
1300 Da), PArg (average MW approximately 10,000 Da),
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDC),
and triethylamine were purchased from Sigma-Aldrich
(St. Louis, MO, USA). DOX was purchased from Calbio-
chem (Merck KGaA, Darmstadt, Germany). Spectra/Por™
dialysis membranes with MW cut-offs of 1000 or
13,000 g/mol were purchased from Spectrum Labs
(Rancho Dominguez, CA, USA). MCF-7 human breast
adenocarcinoma cells and WRL-68 human hepatic cells
were purchased from the American Type Culture Collec-
tion (Manassas, VA, USA). Dulbecco’s modified Eagle’s
medium (DMEM), fetal bovine serum (FBS), trypsin-
ethylenediaminetetraacetic acid (EDTA), and (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
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Synthesis of the CA-PEI-pArg Copolymer
CA-PEI-pArg was prepared by the two-step reaction
method which involves carbodiimide-mediated amida-
tion with EDC and NHS, as described by Li et al. with
minor modification [26] (Scheme 1). In Step 1, CA was
conjugated with PEI at molar ratios of 1:1, 2:1, or 3:1 to
form CA-PEI. To achieve this, CA (47, 94, or 141 mg)
in methanol (10 mL) was activated with EDC (44, 88,
or 132 mg) and NHS (27, 53, or 80 mg) at room
temperature for 6 h. PEI (300 μL) was then added
drop-wise into the activated CA solution while stirring.
The resulting mixture was stirred at room temperature
overnight. The formulation was dialyzed against
500 mL deionized water in a 1000-Da dialysis bag for
48 h and dried by lyophilization.
In step 2, pArg hydrochloride (40 mg) was dissolved in
5 mL methanol, after which 40 μL trimethylamine was
added to remove the HCl salt. After 30 min, CA-PEI
(40 mg) at the molar ratios indicated above, EDCScheme 1 Schematic structure of CA-PEI-pArg triblock copolymer(40 mg), and NHS (24 mg) in methanol (5 mL) were
added drop-wise into the pArg solution. The resulting
mixture was stirred at room temperature overnight,
dialyzed against 500 mL deionized water in a 1000-Da
dialysis bag for 48 h, and dried by lyophilization.
Characterization of the CA-PEI-pArg Copolymer
CA-PEI-pArg was characterized using a Fourier trans-
form infrared (FTIR) spectrophotometer (Spectrum 100;
PerkinElmer, Waltham, MA, USA) and a proton nuclear
magnetic resonance (1H NMR) spectrophotometer
(Bruker Avance III, FT-NMR 600 MHz with cryoprobe;
Germany). For FTIR, samples were prepared by
compressing the polymers into pellets with potassium
bromide. FTIR spectra were recorded over 4000-500 cm
−1. For 1H NMR, chloroform-d (CDCl3) was used as the
solvent. 1H NMR spectra were recorded at 400 MHz.
Preparation of DOX-Loaded CA-PEI-pArg PMs
DOX-loaded CA-PEI-pArg PMs were prepared by emul-
sification method, as described by Wahab et al. with
minor modification [27]. DOX was prepared by
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mixed with triethylamine (2 μL). Excess triethylamine
and byproducts were removed by dialysis against
200 mL deionized water in a 1000-Da dialysis bag for
24 h and dried by lyophilization. DOX (5 mg) was dis-
solved in 2 mL dimethyl sulfoxide, and CA-PEI-PArg co-
polymers (20 mg) of different molar ratios were
dissolved in 5 mL methanol. The DOX solution and
CA-PEI-PArg copolymer solution were mixed in a glass
vial, kept in the dark for 24 h, and added drop-wise into
deionized water (10 mL) under ultrasonic agitation using
a Sonifier (Branson Ultrasonics Co., Danbury, CT, USA)
at a power of 3 Hz for 10 min. The solvent was evapo-
rated using a rotary evaporator. The DOX-loaded mi-
celle solution was filtered through a syringe membrane
filter (0.4 μm) to remove undissolved DOX. The final
product was dried by lyophilization.Characterization of the CA-PEI-pArg PMs
The CMC of the PMs was determined using dynamic
light scattering (DLS) (Zetasizer Nano ZS; Malvern
Instruments, Malvern, Worcestershire, UK) at 37 °C
with a scattering angle of 90°. The changes in light
intensity were recorded for a series of copolymer sus-
pensions at different concentrations. The sample molar
concentration was plotted against the mean light inten-
sity. The CMC was the concentration at which a sharp
increase in scattering intensity occurred, indicating
micelle formation.
Blank and DOX-loaded CA-PEI-pArg PMs (1 mg/
mL) were prepared in phosphate-buffered saline (PBS;
pH 5.0, 6.0, 6.5, or 7.4). The particle size and zeta
potential of the PMs were determined using a
Zetasizer Nano ZS (Malvern Instruments) 24 h after
preparation. Results were expressed as the average of
triplicate measurements.
The morphology of the micelles was analyzed by trans-
mission electron microscopy (TEM; Tecnai™ Spirit, FEI,
Eindhoven, Netherlands). Blank and DOX-loaded
CA-PEI-pArg PMs were prepared in deionized water
(1 mg/mL). A drop of PM suspension containing 0.2%
(w/v) phosphotungstic acid was placed on a copper grid
and allowed to dry at room temperature. PM morph-
ology was observed by TEM at an acceleration voltage
of 220 kV with various degrees of magnification.Drug Loading Content and Entrapment Efficiency
The amount of DOX loaded into the PMs was deter-
mined in reference to a standard curve of free DOX.
Freeze-dried DOX-loaded CA-PEI-pArg PMs were
suspended in deionized water (2 mL), and absorbance
was measured at 480 nm using a UV-1601 spectropho-
tometer (Shimadzu Corp., Kyoto, Japan). Drug loadingcontent (DLC) and entrapment efficiency (EE) were
calculated by Eqs. (1) and (2).
DLC %ð Þ ¼ ðmass of drug encapsulated in micelles
=mass of drug‐loaded micellesÞ  100
ð1Þ
EE %ð Þ ¼ ðmass of drug encapsulated in micelles
=mass of drug initially addedÞ  100
ð2Þ
In Vitro Drug Release from PMs
DOX release studies were carried out using in vitro dialy-
sis at pH 5.0 and pH 7.4. Briefly, freeze-dried DOX-loaded
CA-PEI-pArg PMs (equally to 100 μg/mL of DOX) were
suspended in deionized water (5 mL). The DOX-loaded
PM suspension was placed into 13,000-Da dialysis tubing
and dialyzed against 100 mL PBS (pH 5.0 or 7.4) under
stirring at 100 rpm at 37 °C. At suitable intervals, 2-mL
samples were withdrawn from the release medium and
replaced with an equal volume of fresh medium. The
released DOX was determined by a UV–VIS spectropho-
tometer at 480 nm (UV-1601; Shimadzu).
f2 Similarity Test
The release data were fitted to the f2 equation to investi-
gate the closeness of DOX release profiles from CA-PEI-
pArg PMs between pH 7.4 and 5.0. The following
equation was used to calculate similarity factors [28].








In the equation, Rt and Tt representing the cumulative
percentage released at each of the selected n time points
under pH 7.4 and 5.0, respectively. f2 was described as a
similarity factor. The factor f2 is a logarithmic reciprocal
square root transformation of the sum of squared error
and it is showing the percentage similarity between the
two curves [29].
Cellular Uptake Study
MCF-7 cells (2.5 × 105 cells/well) were seeded on cover
slips placed in six-well plates and allowed for cell attach-
ment by incubating for 24 h. The cells were then treated
with free DOX solution, DOX-loaded CA-PEI PMs, or
DOX-loaded CA-PEI-pArg PMs (10 μg/mL), and incu-
bated for 1, 4, or 24 h. Di-block CA-PEI PMs were
prepared by carbodiimide-mediated amidation and DOX
were loaded with emulsification method, as described by
Wahab et al. with minor modification [27]. At the desig-
nated time points, the medium was discarded and the
cells were rinsed twice with cold PBS. The cell nuclei
were then stained by Hoechst 33342 for 10 min in
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for 30 min to fix the cells. Finally, the cells were washed
twice with cold PBS and mounted on microscope slides
using buffered mounting medium. The cells were
observed by using confocal laser scanning microscopy
(CLSM; TCS SP5, Leica Microsystems, Mannheim,
Germany).
The cellular uptake of DOX by MCF-7 cells was
analyzed quantitatively by flow cytometry. Owing to the
intrinsic fluorescence of DOX, DOX was used as a fluor-
escent indicator to study the uptake of DOX-loaded
PMs. Briefly, cells (1 × 106 cells/well) were seeded in
six-well plates, incubated for 24 h, treated with free
DOX solution, DOX-loaded CA-PEI PMs, or DOX-
loaded CA-PEI-pArg PMs (5 μg/mL), and incubated for
1 or 4 h. Negative control cells were treated with blank
micelles. After incubation, the cells were harvested with
trypsin-EDTA and resuspended in PBS. The cell suspen-
sion was analyzed using a FACS Calibur flow cytometer
(BD Biosciences, Franklin Lakes, NJ) and 10,000 events
were collected for each sample.
Cellular and Nuclear Morphology
MCF-7 cells (5.0 × 105 cells/well) were seeded on cover
slips placed in six-well plates and incubated for 24 h.
The cells were then treated with free DOX solution or
DOX-loaded CA-PEI-pArg PMs (5 μg/mL) for 24 h. The
untreated cells were used as a negative control group.
After incubation, the medium was removed and the cells
were washed twice with cold PBS. The cells were then
stained by Hoechst 33342 for 10 min in darkness and
fixed with 4% paraformaldehyde for 30 min. Finally, the
cells were mounted on microscope slides using a buff-
ered mounting medium after washed twice with cold
PBS. The cells were observed using CLSM (TCS SP5)
and inverted light microscope (Olympus FluoView
FV-1000; Olympus Optical Co., Ltd., Tokyo, Japan).
Subcellular Localization
MCF-7 cells (2.5 × 105 cells/well) were seeded on cover
slips placed in six-well plates and incubated for 4 h. The
cells were then treated with free DOX solution, DOX-
loaded CA-PEI PMs, or DOX-loaded CA-PEI-pArg PMs
(5 μg/mL) for 4 h and washed twice with cold PBS. The
cells were stained with Lysotracker Green (100 nM) for
30 min and Hoechst 33342 (10 μg/mL) for 10 min in
darkness to visualize the lysosomes and nuclei, respect-
ively. The cells were washed twice with cold PBS and
fixed with 4% paraformaldehyde for 30 min. The fixed
cells were observed by using CLSM (TCS SP5).
In Vitro Cytotoxicity Study
The cytotoxicity of blank micelles and DOX-loaded
micelles were assessed using WRL-68 and MCF-7 cells,which were cultured routinely in DMEM supplemented
with 10% FBS and 1% penicillin-streptomycin in a
humidified atmosphere of 5% CO2 at 37 °C. Cells were
seeded in 96-well plates (2 × 104 cells/well for WRL-68
cells and 1 × 104 cells/well for MCF-7 cells) and incu-
bated for 24 h. Blank micelles (3.91–250 μg/mL) were
added to WRL-68 cells and MCF-7 cells. Free DOX and
DOX-loaded micelles were added to MCF-7 cells
(1.562–50 μg/mL). The untreated cells were used as a
negative control group. All the cells were incubated for
24 h at 37 °C in a 5% CO2/95% air atmosphere. After
this 24-h incubation, 20 μL MTT solution (Invitrogen,
Carlsbad, CA, USA) was added to each well and the cells
were incubated for 4 h. Crystalline formazan was dis-
solved using acidified isopropyl alcohol (0.04 N HCl).
The absorbance of each sample was measured using a
microplate reader (Varioskan Flash; Thermo Scientific,
Waltham, MA, USA) at 570 nm.Statistical Analysis
Values are presented as the mean ± standard error of the
mean of triplicate measurements. The statistical signifi-
cance of differences was tested using two-way analysis of
variance. The level of significance was set at α = 0.05.Results and Discussion
Synthesis and Characterization of CA-PEI-pArg Copolymer
Synthesis of the pH-sensitive CA-PEI-pArg copolymer
was achieved by the two-step reaction process illustrated
in Scheme 1. The carboxyl groups of CA and pArg were
activated by EDC to form an active O-acylisourea inter-
mediate that was readily displaced by the nucleophilic
attack of the amine group of PEI. The primary amine
groups of PEI then formed an amide linkage with the
carboxyl group of CA. PEI with a MW of 1300 Da was
used throughout the study because low-MW PEI could
minimize the cytotoxicity of PEI [13]. pArg with a low
MW of 10 kDa was used to facilitate renal clearance of
pArg after the disintegration of CA-PEI-pArg copoly-
mers in the blood circulation, thus reducing the poten-
tial for toxicity [30].
The structure of the CA-PEI-pArg copolymer was
characterized by FTIR and 1H NMR (Fig. 1). In Fig. 1i
(e), FTIR peaks for N–H stretching, C–H stretching,
C=O stretching, and N–H bending appeared at wave-
lengths of 2969, 2867, 1653, and 1564 cm−1, respectively,
indicating the presence of an amide linkage in the
copolymer. FTIR spectra from different sets of CA-PEI-
pArg samples showed consistent results, indicating the
formation of the amide linkage in all of the formulations.
Although the spectra clearly demonstrated the presence
of an amide linkage, incorporation of pArg into the CA-
PEI copolymer could not be confirmed, because both
Fig. 1 i The FTIR spectra of pH-sensitive CA-PEI-pArg copolymer. (a)
CA, (b) PEI, (c) CA-PEI, (d) pArg, (e, f, g) CA-PEI-pArg. ii 1H NMR
spectrum of (a) CA, (b) PEI, (c) pArg, and (d) CA-PEI-pArg
Fig. 2 a Critical micelle concentrations (CMC) of CA-PEI-pArg PMs.
b Physicochemical properties of blank and DOX-loaded CA-PEI-pArg
PMs (mean ± SEM, n = 3)
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within the same absorbance range.
Formation of the CA-PEI-pArg copolymer was con-
firmed by 1H NMR. As shown in Fig. 1ii (d), proton
shifts were detected from 1.0-2.4 ppm, demonstrating
the presence of CA in the copolymer. Doublet, triplet,and multiplet peaks were representative of the CA struc-
ture. Proton shifts from 3.1-4.0 ppm were characteristic
of carbonyl bonds. These results demonstrated the pres-
ence of an amide linkage in the CA-PEI-pArg copoly-
mer. In addition, comparison of the 1H NMR spectra of
the triblock copolymer (Fig. 1ii (d)) with those of the
other components (Fig. 1ii (a–c)) showed that distinct
chemical shifts attributable to different components
were present in the spectrum of the CA-PEI-pArg
copolymer. These results confirmed the synthesis of the
triblock copolymer.
Characterization of CA-PEI-pArg PMs
Block copolymers self-assemble and rearrange to form
PMs above their particular CMC. The CMCs of CA-
PEI-pArg PMs with different molar ratios are shown in
Fig. 2a. An abrupt increase in light intensity was mea-
sured via DLS, indicating micelle formation. The CMCs
for PMs with CA:PEI molar ratios of 3:1 (2.98 × 10−7 M)
and 2:1 (2.98 × 10−7 M) were lower than that of PMs
with a molar ratio of 1:1 (5.96× 10−7 M). The ratio of
hydrophilic to hydrophobic segments affects the CMC
[31]. CA has a hydrophobic steroidal nucleus in its
molecular structure, and increased CA substitution may
therefore enhance the hydrophobic interactions between
the block copolymers in the core region of the micelle,
allowing copolymers to stabilize and self-assemble into
micellar structures at lower concentrations. Lower
CMCs improve micelle stability in dynamic in vivo
systems. It is essential that intravenously administered
micelles maintain their integrity in blood vessels and it
is therefore crucial that clinically used micelles have low
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dilution effect following administration.
The zeta potential of the micelles was determined and
recorded (Fig. 2b). Zeta potential can influence particle
stability in dispersion due to the electrostatic repulsion
between particles with same type of charge. As expected,
all the blank and DOX-loaded PMs possessed a positive
surface charge due to the high density of amines on the
hydrophilic shell. This would prevent agglutination of
PMs in the dispersion. DOX-loaded PMs showed a
higher zeta potential than blank PMs. This increase in
zeta potential reflected the increase in particle size, due
to the entrapped DOX. Cellular membranes exhibit
anionic surface charges due to the presence of phospho-
lipid bilayer and membrane-bound proteins [32]. There-
fore, electrostatic interaction of cationic PMs with
cellular membranes could enhance nanoparticle intern-
alization and improve cellular uptake of DOX. However,
the zeta potential must be monitored carefully because
strongly cationic polymers can be highly cytotoxic [33].
Hence, PMs with CA:PEI molar ratios of 2:1 and 3:1 had
an advantage over those with a 1:1 ratio due to their
lower zeta potential, which would possibly cause lower
toxicity.
DOX encapsulation in the CA-PEI-pArg PMs was
evaluated by measuring DLC and EE. Of the tested
formulations, PMs with a molar ratio of 2:1 had the
highest DLC (9.5% w/w) and EE (34.2% w/w). It was
hypothesized that hydrophobic DOX would interact with
the hydrophobic block copolymers in an aqueous envir-
onment and become trapped within the core regions of
the micelles. Therefore, PM hydrophobicity could affect
its capacity to encapsulate hydrophobic drugs. The PMsFig. 3 a Particle sizes of pH-responsive blank CA-PEI-pArg PMs at pH 5.0, 6
CA-PEI-pArg PMs at pH 5.0, 6.0, 6.5, and 7.4. c TEM images of blank and DO
CA-PEI-pArg PMs at pH 7.4 and (ii) DOX-loaded CA-PEI-pArg PMs at pH 7.4with molar ratios of 2:1 and 3:1 had greater degrees of
CA substitution than the PMs with a molar ratio of 1:1,
conferring a greater DLC. The physicochemical proper-
ties of CA-PEI-pArg PMs are summarized in Fig. 2b.
pH Sensitivity of the PMs
The particle sizes of the blank and DOX-loaded CA-
PEI-pArg PMs were determined at different pH values
by DLS. The CA-PEI-pArg triblock copolymers (1 mg/
mL) of different CA:PEI molar ratios were suspended in
PBS (pH 5.0, 6.0, 6.5, or 7.4) and micellar size was
recorded (Fig. 3a, b). At pH 7.4, average sizes of both
blank and DOX-loaded PMs with different molar ratios
ranged from 107.4 to 219.2 nm. As the pH decreased,
the micellar sizes of all tested PMs increased markedly.
The particle size of the blank and DOX-loaded PMs with
a 2:1 molar ratio increased from 107.4 to 692.2 nm
(approximately sevenfold) and from 163.8 to 1357.7 nm
(approximately eightfold), respectively, with a decrease
in pH from 7.4 to 5.0. In CA-PEI-pArg PMs, the amide
linkage of PEI (with a high amine content) between
hydrophilic pArg and amphiphilic CA serves as the pH-
sensitive moiety. It was hypothesized that ionization of
copolymer groups altered the polymer conformation as
the pH and ionic composition of the aqueous medium
changed [34]. Therefore, the amine groups of PEI
became protonated and altered conformation in acidic
environments. In addition, protonated amine groups
possess a greater charge density, resulting in stronger
electrostatic repulsion among the hydrophilic moieties,
which leads to a swollen micellar structure and a greater
PM size [15, 34]. PMs with a CA:PEI molar ratio of 2:1
showed a greater size increase than those with molar.0, 6.5, and 7.4. b Particle sizes of pH-responsive DOX-loaded
X-loaded CA-PEI-pArg PMs with CA:PEI molar ratio 2:1. (i) Blank
(mean ± SEM, n = 3)
Fig. 4 Release profiles of pH-responsive CA-PEI-pArg PMs at a pH
7.4 and b pH 5.0 (mean ± SEM, n = 3)
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increasing the degree of CA substitution directly affected
the amount of free amine groups in the copolymers. The
PMs with the 3:1 molar ratio had the fewest free amine
groups; electrostatic repulsion between the hydrophilic
block copolymers was therefore weaker than that
observed in the PMs with other molar ratios. In
addition, the increase in CA substitution also increased
the hydrophobicity of the copolymer, resulting in stron-
ger hydrophobic interactions within the core region and
stabilization of the PM structure [35]. Surprisingly, PMs
with a 1:1 molar ratio showed a smaller change in size
than PMs with a 2:1 molar ratio, perhaps reflecting the
high hydrophilicity conferred by pArg (there are more
primary amine groups on PEI, which are readily
conjugated by pArg). The increased hydrophilic to
hydrophobic ratio could stabilize the PM structure due
to hydrogen bonding between lone-pair electrons in
amines and protons in water molecules.
The morphology of blank and DOX-loaded CA-PEI-
pArg PMs was observed by TEM (Fig. 3c). The micelles
exhibited a uniform spherical morphology at all tested
molar ratios. The micellar size determined by TEM was
slightly smaller than that measured by DLS, because the
sizes obtained from the DLS measurements represent
the hydrodynamic diameter in a micellar suspension
whereas the TEM sample preparation involved a drying
process that slightly shrank the micelles [36, 37].
The release profiles of DOX-loaded PMs were studied
at pH 7.4 and pH 5.0 (Fig. 4). PMs at all tested molar ra-
tios demonstrated an initial burst release of loaded DOX
in the first 12 h and achieved sustained release after
24 h. A similar burst release phenomenon has been
reported by many researchers [38–40]. A small amount
of DOX adsorbs to the hydrophilic region, instead of
within hydrophobic core, due to the electrostatic inter-
action between DOX and the hydrophilic copolymers
during micelle self-assembly. During the release process,
these DOX molecules desorb from the micelles more
readily than DOX loaded in the inner core, causing an
initial burst release [39]. As shown in Fig. 4, DOX re-
lease from the PMs occurred much more rapidly at pH
5.0 than at pH 7.4. At pH 5.0 (Fig. 4b), PMs with a 2:1
molar ratio showed greater cumulative release (65%)
after 6 days than the PMs with 1:1 or 3:1 molar ratios
(56%). The increased release rate at acidic pH values was
due to amine group protonation, which led to conform-
ational changes and swelling of the micellar structure.
At pH 7.4 (Fig. 4a), PMs with a 2:1 molar ratio released
less DOX (32%) after 6 days than the PMs with 1:1
(36%) or 3:1 (38%) molar ratios. The rate of drug release
from PMs with a 2:1 molar ratio plateaued after the first
48 h at pH 7.4, but gradually increased at pH 5.0, even
after 5 days. This finding is relevant for the safety profileof DOX-loaded PMs, because the pH dependence of re-
lease facilitates secure circulation of the encapsulated
drug in the blood and increases the release rate at the
more acidic tumor interstitium. These findings (Fig. 4)
were consistent with the DLS results (Fig. 3a, b). The
PMs with a 2:1 molar ratio had the smallest size at pH
7.4 and released the least DOX, but their size drastically
increased at pH 5.0 and they showed the greatest cumu-
lative DOX release under these conditions. These
findings show that a molar ratio of 2:1 is ideal for DOX
delivery using CA-PEI-pArg PMs.
f2 Similarity Test
The closeness of DOX release from CA-PEI-pArg PMs
between pH 7.4 and 5.0 was investigated by fitting the
release data to f2 equation (Table 1). Fitting of these data
to f2 equation resulted in f2 values 73.11, 31.58, and
43.56, respectively, for CA-PEI-PArg PMs with molar
ratios 1:1, 2:1, and 3:1. According to similarity factor f2,
two profiles are considered to be alike when the f2 value
is equal to 100. When the f2 value falls between 50 and
100, the difference between two profiles at each
sampling time are less than or equal to 10% [41]. The
Table 1 f2 similarity test for DOX release from CA-PEI-pArg PMs
at pH 7.4 and 5.0
CA-PEI-pArg PMs
X
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release results at each sampling time for PMs with molar
ratio 1:1 are less than 10%. On the other hand, the dif-
ferences in DOX release rate from PMs with molar ratio
2:1 and 3:1 between pH 7.4 and 5.0 were recorded
higher than 10%. Among all the PMs, molar ratio 2:1 re-
corded the lowest f2 values which is 31.58, indicated that
the DOX release rate from PMs was very different in pH
5.0 as compared to pH 7.4.
In Vitro Cellular Uptake
To evaluate the cellular uptake efficiency, CLSM was used
to localize DOX in MCF-7 cells. The CLSM images of
MCF-7 cells after 1-, 4-, and 24-h incubations with free
DOX solution, DOX-loaded CA-PEI PMs, or DOX-loaded
CA-PEI-pArg PMs (10 μg/mL) are shown in Fig. 5. Weak
red fluorescence was observed in MCF-7 cells incubated
with free DOX for 1 h and 4 h (Fig. 5a (i, ii)). This red
fluorescence was almost absent in MCF-7 cells incubated
with free DOX for 24 h (Fig. 5a (iii)). This result suggested
that the DOX has been removed from the cytoplasm and
it could be due to the active removal of DOX by P-gpFig. 5 CLSM images of a free DOX solution, b DOX-loaded CA-PEI
PMs, and c DOX-loaded CA-PEI-pArg PMs (CA:PEI molar ratio 2:1) in
MCF-7 cells after incubation time of (i) 1 h, (ii) 4 h, and (iii) 24 h. Blue
and red fluorescence indicate nuclei and DOX, respectivelyefflux pump. However, a greater red fluorescence intensity
was observed in MCF-7 cells treated with DOX-loaded
CA-PEI-pArg PMs (Fig. 5c) as compared to MCF-7 cells
treated with DOX-loaded CA-PEI PMs (Fig. 5b) or free
DOX, even after 24 h (Fig. 5c (iii)). The cellular uptake of
DOX showed a time-dependent trend, with enhanced red
fluorescence intensity observed as the incubation time in-
creased from 1 h to 4 h (Fig. 5a–c (i, ii)]), in accordance to
the flow cytometry results (Fig. 6). These results suggested
that the use of DOX-loaded CA-PEI-pArg PMs enhanced
the intracellular accumulation of DOX in MCF-7 cells, as
compared to the use of the free DOX solution and DOX-
loaded CA-PEI-pArg PMs. The results also showed that
the cellular uptake of DOX has been improved with the
presence of cell-penetrating pArg peptide in triblock PMs.
Cellular DOX uptake was also evaluated quantitatively
by flow cytometry after 1 h and 4 h incubations. Intrinsic
DOX fluorescence was detected in MCF-7 cells treated
with DOX (Fig. 6 (ii-iv)), whereas no DOX fluorescence
was detected in negative control cells (Fig. 6 (i)). As shown
in Fig. 6, the fluorescence signal will appear in the right
quadrant if MCF-7 cells had taken up the DOX, whereas
the fluorescence signal will appear in the left quadrant if
there is no DOX signal being detected in the MCF-7 cells.
Result shows that the DOX fluorescence was detected in
34.2% (Fig. 6a (ii)) and 63.2% (Fig. 6b (ii)) of MCF-7 cells
which were treated with free DOX solution for 1 h and
4 h, respectively. The percentage of MCF-7 cells detected
with DOX fluorescence was recorded to be higher in
MCF-7 cells treated with DOX-loaded CA-PEI-pArg PMs
for 1 h (91.5%) (Fig. 6a (iv)) and 4 h (99.9%) (Fig. 6b (iv)),
as compared to the MCF-7 cells treated with DOX-loaded
CA-PEI PMs for 1 h (77.3%) (Fig. 6a (iii)) and 4 h (97.2%)
(Fig. 6b (iii)). These findings suggest that the use of DOX-
loaded CA-PEI-pArg PMs would achieve greater thera-
peutic efficacy due to enhanced cellular uptake into the
cells. The presence of high amounts of DOX-loaded
CA-PEI-pArg PMs in the MCF-7 cells could also be due
to the small size of the PMs [42] or their cationic surface
charge. The cationic surface charge of the PMs enhances
contact with MCF-7 cells, and the use of small micelles fa-
cilitates internalization. In addition, the presence of pArg
hydrophilic shell was expected to facilitate the cellular
penetration of micelles across cell membrane [43].
Cellular and Nuclear Morphology
The morphologies of MCF-7 cells incubated with free
DOX or DOX-loaded PMs (10 μg/mL) for 24 h were
observed using CLSM and shown in Fig. 7. The cell
nuclei were stained by Hoechst 33342. The cellular and
nuclei morphology for MCF-7 cells exposed to free
DOX solution (Fig. 7b) did not show prominent differ-
ences to the negative control cells (Fig. 7a). The nuclei
morphology of MCF-7 cells exposed to DOX-loaded
Fig. 6 In vitro cellular uptake evaluation by flow cytometry on MCF-7 cells (i) without any treatment, (ii) treated with free DOX, (iii) treated with
DOX-loaded CA-PEI PMs, and (iv) treated with DOX-loaded CA-PEI-pArg PMs after a 1-h and b 4-h incubation
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ences as compared to MCF-7 cells exposed to free DOX
solution (Fig. 7b). However, there is a small number of
nuclei undergone nuclear fragmentation in Fig. 7c but
none were observed in Fig. 7b. In addition, significant
morphological changes were observed in MCF-7 cells
treated with DOX-loaded PMs for 24 h, including cell
shrinkage, cell detachment, and nuclear fragmentation.
These results indicated that MCF-7 cells exposed to
DOX-loaded PMs showed signs of apoptosis more fre-
quently than did cells exposed to the free DOX solution.Fig. 7 Cellular and nuclear morphologies of MCF-7 cells a untreated and afte
PMs (CA:PEI molar ratio 2:1) for 24 hSubcellular Localization
The localization of DOX to the lysosomal compartment in
MCF-7 cells was also observed by CLSM (Fig. 8). The nu-
clei were stained blue by using Hoechst 33342; lysosomes
were stained green by using a Lysotracker Green; and DOX
were appeared as red owing to its intrinsic fluorescence.
Colocalization of DOX with lysosomes appeared as yellow
signal, while non-colocalization appeared as red signal.
MCF-7 cells treated with free DOX solution (Fig. 8a (iv))
showed yellow compartments, suggesting that DOX was
trapped in the lysosomes of MCF-7 cells. The redr treatment with b free DOX solution and c DOX-loaded CA-PEI-pArg
Fig. 8 CLSM images of the subcellular localization of a free DOX solution, b DOX-loaded CA-PEI PMs, and c DOX-loaded CA-PEI-pArg PMs (CA:PEI
molar ratio 2:1) in MCF-7 cells after 4-h incubation: (i) cell nuclei (blue); (ii) lysosomes (green); (iii) DOX (red); and (iv) overlay of all images
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weak. According to the literature, some of the hydrophobic
drugs such as DOX, daunorubicin, mitoxantrone, imidazoa-
cridinones, and sunitinib were reported to accumulate in
the lysosomes instead of cytoplasm [44–48]. At physio-
logical pH, the hydrophobic amine drugs will diffuse across
the cell membrane via passive diffusion. These drugs will
undergo protonation upon entry into the lysosomes or late
endosomes with acidic pH and eventually entrapped in the
lysosome [49]. As a result, the hydrophobic amine drugs
will be sequestered away and prominently reduced the ac-
cumulation of these drugs in the nucleus [50]. In contrast,
MCF-7 cells treated with DOX-loaded CA-PEI-pArg PMs
showed a higher intensity of red fluorescence (Fig. 8c (iv))
as compared to those incubated with DOX-loaded CA-PEI
PMs (Fig. 8b (iv)) or free DOX solution. These results sug-
gested that the use of DOX-loaded CA-PEI-pArg PMs facil-
itates the escape of DOX from the lysosomal compartment,
allowing it to reach the cytoplasmic and nuclear regions of
the MCF-7 cells. In addition, the results of this study are in
consistence with the cellular uptake study as shown in
Fig. 5. The MCF-7 cells exposed to DOX-loaded CA-PEI-
pArg PMs (Fig. 8c (iii)) showed stronger DOX fluorescence
signal than those exposed to free DOX solution (Fig. 8a
(iii)) or DOX-loaded CA-PEI PMs (Fig. 8b (iii)), indicated
improved cellular uptake of DOX-loaded PMs into the
MCF-7 cells. Apart from the improved cellular uptake
efficiency, the incorporation of pArg into CA-PEI-pArg
copolymer was also shown to improve the escape of DOX
from lysosome. This could be a contribution from the
protonation of amine groups in pArg under acidicenvironment, which would lead to osmolarity changes in
the lysosome and eventually destabilize the lysosome
structure.
In Vitro Cytotoxicity of PM
The safety profile of blank CA-PEI-pArg PMs in WRL-
68 cells and MCF-7 cells were evaluated by MTT assay
(Fig. 9a, b). More than 90% of cells were viable at all
tested concentrations, suggesting that the blank micelles
were not toxic to WRL-68 cells and MCF-7 cells at con-
centrations of ≤250 μg/mL. These results indicated that
the blank PMs did not cause cytotoxic or inhibitory ef-
fects on human hepatic cells (WRL-68) or breast cancer
cells (MCF-7).
The effect of DOX-loaded CA-PEI-pArg PMs on cell
viability was examined using MCF-7 cells. MCF-7 cells
were treated with DOX-loaded PMs or free DOX solu-
tion (1.562–50 μg/mL). After 24-h incubations, cell via-
bility was assessed by the MTT assay (Fig. 9c). The
inhibitory effect of DOX-loaded PMs (3.13–50 μg/mL)
on MCF-7 cells was greater than that of the free DOX
solution. The cell viability of MCF-7 cells treated with
DOX-loaded PMs (3.13 – 12.5 μg/mL) were significantly
lower than MCF-7 cells treated with free DOX solution.
These MTT results were consistent with the results of
the cellular uptake experiments, confirming that the
PM-associated increased penetration of DOX through
the cell membrane resulted in a greater inhibitory effect.
These findings also suggested that the proton sponge
effect of PEI successfully triggered endosome escape and
release of the drug into the cytoplasm. Accumulation of
Fig. 9 a Cytotoxicity of blank CA-PEI-pArg PMs (CA:PEI molar ratio 2:1) in WRL-68 cells after 24 h. b Cytotoxicity of blank CA-PEI-pArg PMs in
MCF-7 cells after 24 h. c Cytotoxicity of DOX-loaded CA-PEI-pArg PMs (CA:PEI molar ratio 2:1) in MCF-7 cells after 24 h (mean ± SEM, n = 3;
*P ≤ 0.05, ***P ≤ 0.001)
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enhance the cytotoxicity of DOX. However, the cytotox-
icity effect of DOX-loaded PMs was slightly lower than
free DOX at concentration of 1.56 μg/mL; this may re-
flect over-dilution of DOX-loaded PMs during the prep-
aration of the formulations using serial dilution. No
micelle formation occurs when the concentration of
block copolymers is lower than the CMC. Therefore,
there is no significant difference between the cytotoxicity
effect caused by loaded DOX and free DOX at concen-
tration 1.56 μg/mL.
Conclusions
In this study, a pH-responsive drug delivery system was
developed to evaluate its efficacy for delivering DOX to
human breast cancer MCF-7 cells. FTIR and 1H NMR
confirmed the successful synthesis of triblock CA-PEI-
pArg copolymers. Inclusion of a pH-sensitive block
(PEI) conferred pH-dependent changes in particle size,
drug release profiles, and drug release kinetics. Inclusion
of pArg as a hydrophilic shell increased cellular uptake
and enhanced the cytotoxicity of DOX-loaded PMs to
MCF-7 cells. This study indicates that controlled release
of anticancer drugs at acidic pH values can be achieved
using pH-responsive PMs. The combination of pH-
dependent drug release, a cell-penetrating peptide, and
proton sponge-triggered endosomal escape produced a
robust pH-responsive drug delivery system with high
efficacy, warranting further investigation.Acknowledgements
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